GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » Total Stockholders Equity

Lophos Holdings (XCNQ:MESC) Total Stockholders Equity : C$1.48 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Lophos Holdings Total Stockholders Equity?

Lophos Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$1.48 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lophos Holdings's Book Value per Share for the quarter that ended in Mar. 2024 was C$0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lophos Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 was 1.39.

Lophos Holdings Total Stockholders Equity Historical Data

The historical data trend for Lophos Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lophos Holdings Total Stockholders Equity Chart

Lophos Holdings Annual Data
Trend Mar22 Mar23 Mar24
Total Stockholders Equity
2.23 1.48 1.48

Lophos Holdings Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 1.48 1.46 1.85 1.72 1.48

Lophos Holdings  (XCNQ:MESC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lophos Holdings's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.479-0)/85.8597
=0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lophos Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(2.058 + 0) / 1.479
=1.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lophos Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Lophos Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lophos Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » Total Stockholders Equity
Comparable Companies
TSXV:IOT TSX:APLI XCNQ:MBIO TSXV:RP XCNQ:NOVA XCNQ:BIOV XCNQ:GLOW TSXV:MRVL TSXV:RKV TSX:IPCI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
1111 Melville Street, Suite 620, Vancouver, BC, CAN, V6E 3V6
Website
Lophos Holdings Inc is engaged in the y is the cultivation of peyote and the manufacture of Lophophora compounds, including Mescaline, as well as formulation of novel Lophophora-based compounds.
Executives
John Ioannis Karagiannidis Director
Evan Stawnyczy Director

Lophos Holdings Headlines

No Headlines